Medical Care

Global GMP Viral Vector Manufacturing Market Research Report 2025

The global market for GMP Viral Vector Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
GMP viral vector manufacturing is the manufacturing of viral vectors, such as adenoviruses or lentiviruses, under Good Manufacturing Practices (GMP) standards for use in gene therapy and vaccine production. This process ensures the safety and quality of the viral vectors for medical applications.
North American market for GMP Viral Vector Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GMP Viral Vector Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of GMP Viral Vector Manufacturing include Advanced BioScience Laboratories, Biovian, Lonza, Takara Bio, Genezen, Halix, Merck, Batavia Biosciences, Exothera, WuXi Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for GMP Viral Vector Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Viral Vector Manufacturing.
The GMP Viral Vector Manufacturing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GMP Viral Vector Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Viral Vector Manufacturing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Advanced BioScience Laboratories
Biovian
Lonza
Takara Bio
Genezen
Halix
Merck
Batavia Biosciences
Exothera
WuXi Biologics
Vectorbuilder
Abace-Biology
Genscript
Cytiva
Obiosh
Pregene
Segment by Type
Adenovirus Vector Manufacturing
AAV Vector Manufacturing
Retroviral Vector Manufacturing
Lentiviral Vector Manufacturing
Others
Segment by Application
Clinical Research
Commercial Production
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GMP Viral Vector Manufacturing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GMP Viral Vector Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 GMP Viral Vector Manufacturing Market Overview
1.1 Product Definition
1.2 GMP Viral Vector Manufacturing by Type
1.2.1 Global GMP Viral Vector Manufacturing Market Value Comparison by Type (2024 VS 2031)
1.2.2 Adenovirus Vector Manufacturing
1.2.3 AAV Vector Manufacturing
1.2.4 Retroviral Vector Manufacturing
1.2.5 Lentiviral Vector Manufacturing
1.2.6 Others
1.3 GMP Viral Vector Manufacturing by Application
1.3.1 Global GMP Viral Vector Manufacturing Market Value by Application (2024 VS 2031)
1.3.2 Clinical Research
1.3.3 Commercial Production
1.3.4 Others
1.4 Global GMP Viral Vector Manufacturing Market Size Estimates and Forecasts
1.4.1 Global GMP Viral Vector Manufacturing Revenue 2020-2031
1.4.2 Global GMP Viral Vector Manufacturing Sales 2020-2031
1.4.3 Global GMP Viral Vector Manufacturing Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GMP Viral Vector Manufacturing Market Competition by Manufacturers
2.1 Global GMP Viral Vector Manufacturing Sales Market Share by Manufacturers (2020-2025)
2.2 Global GMP Viral Vector Manufacturing Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GMP Viral Vector Manufacturing Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GMP Viral Vector Manufacturing, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GMP Viral Vector Manufacturing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GMP Viral Vector Manufacturing, Product Type & Application
2.7 Global Key Manufacturers of GMP Viral Vector Manufacturing, Date of Enter into This Industry
2.8 Global GMP Viral Vector Manufacturing Market Competitive Situation and Trends
2.8.1 Global GMP Viral Vector Manufacturing Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GMP Viral Vector Manufacturing Players Market Share by Revenue
2.8.3 Global GMP Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GMP Viral Vector Manufacturing Market Scenario by Region
3.1 Global GMP Viral Vector Manufacturing Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GMP Viral Vector Manufacturing Sales by Region: 2020-2031
3.2.1 Global GMP Viral Vector Manufacturing Sales by Region: 2020-2025
3.2.2 Global GMP Viral Vector Manufacturing Sales by Region: 2026-2031
3.3 Global GMP Viral Vector Manufacturing Revenue by Region: 2020-2031
3.3.1 Global GMP Viral Vector Manufacturing Revenue by Region: 2020-2025
3.3.2 Global GMP Viral Vector Manufacturing Revenue by Region: 2026-2031
3.4 North America GMP Viral Vector Manufacturing Market Facts & Figures by Country
3.4.1 North America GMP Viral Vector Manufacturing Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GMP Viral Vector Manufacturing Sales by Country (2020-2031)
3.4.3 North America GMP Viral Vector Manufacturing Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GMP Viral Vector Manufacturing Market Facts & Figures by Country
3.5.1 Europe GMP Viral Vector Manufacturing Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GMP Viral Vector Manufacturing Sales by Country (2020-2031)
3.5.3 Europe GMP Viral Vector Manufacturing Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GMP Viral Vector Manufacturing Market Facts & Figures by Region
3.6.1 Asia Pacific GMP Viral Vector Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GMP Viral Vector Manufacturing Sales by Region (2020-2031)
3.6.3 Asia Pacific GMP Viral Vector Manufacturing Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GMP Viral Vector Manufacturing Market Facts & Figures by Country
3.7.1 Latin America GMP Viral Vector Manufacturing Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GMP Viral Vector Manufacturing Sales by Country (2020-2031)
3.7.3 Latin America GMP Viral Vector Manufacturing Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GMP Viral Vector Manufacturing Market Facts & Figures by Country
3.8.1 Middle East and Africa GMP Viral Vector Manufacturing Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GMP Viral Vector Manufacturing Sales by Country (2020-2031)
3.8.3 Middle East and Africa GMP Viral Vector Manufacturing Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GMP Viral Vector Manufacturing Sales by Type (2020-2031)
4.1.1 Global GMP Viral Vector Manufacturing Sales by Type (2020-2025)
4.1.2 Global GMP Viral Vector Manufacturing Sales by Type (2026-2031)
4.1.3 Global GMP Viral Vector Manufacturing Sales Market Share by Type (2020-2031)
4.2 Global GMP Viral Vector Manufacturing Revenue by Type (2020-2031)
4.2.1 Global GMP Viral Vector Manufacturing Revenue by Type (2020-2025)
4.2.2 Global GMP Viral Vector Manufacturing Revenue by Type (2026-2031)
4.2.3 Global GMP Viral Vector Manufacturing Revenue Market Share by Type (2020-2031)
4.3 Global GMP Viral Vector Manufacturing Price by Type (2020-2031)
5 Segment by Application
5.1 Global GMP Viral Vector Manufacturing Sales by Application (2020-2031)
5.1.1 Global GMP Viral Vector Manufacturing Sales by Application (2020-2025)
5.1.2 Global GMP Viral Vector Manufacturing Sales by Application (2026-2031)
5.1.3 Global GMP Viral Vector Manufacturing Sales Market Share by Application (2020-2031)
5.2 Global GMP Viral Vector Manufacturing Revenue by Application (2020-2031)
5.2.1 Global GMP Viral Vector Manufacturing Revenue by Application (2020-2025)
5.2.2 Global GMP Viral Vector Manufacturing Revenue by Application (2026-2031)
5.2.3 Global GMP Viral Vector Manufacturing Revenue Market Share by Application (2020-2031)
5.3 Global GMP Viral Vector Manufacturing Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Advanced BioScience Laboratories
6.1.1 Advanced BioScience Laboratories Company Information
6.1.2 Advanced BioScience Laboratories Description and Business Overview
6.1.3 Advanced BioScience Laboratories GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Advanced BioScience Laboratories GMP Viral Vector Manufacturing Product Portfolio
6.1.5 Advanced BioScience Laboratories Recent Developments/Updates
6.2 Biovian
6.2.1 Biovian Company Information
6.2.2 Biovian Description and Business Overview
6.2.3 Biovian GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Biovian GMP Viral Vector Manufacturing Product Portfolio
6.2.5 Biovian Recent Developments/Updates
6.3 Lonza
6.3.1 Lonza Company Information
6.3.2 Lonza Description and Business Overview
6.3.3 Lonza GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Lonza GMP Viral Vector Manufacturing Product Portfolio
6.3.5 Lonza Recent Developments/Updates
6.4 Takara Bio
6.4.1 Takara Bio Company Information
6.4.2 Takara Bio Description and Business Overview
6.4.3 Takara Bio GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takara Bio GMP Viral Vector Manufacturing Product Portfolio
6.4.5 Takara Bio Recent Developments/Updates
6.5 Genezen
6.5.1 Genezen Company Information
6.5.2 Genezen Description and Business Overview
6.5.3 Genezen GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Genezen GMP Viral Vector Manufacturing Product Portfolio
6.5.5 Genezen Recent Developments/Updates
6.6 Halix
6.6.1 Halix Company Information
6.6.2 Halix Description and Business Overview
6.6.3 Halix GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Halix GMP Viral Vector Manufacturing Product Portfolio
6.6.5 Halix Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck GMP Viral Vector Manufacturing Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Batavia Biosciences
6.8.1 Batavia Biosciences Company Information
6.8.2 Batavia Biosciences Description and Business Overview
6.8.3 Batavia Biosciences GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Batavia Biosciences GMP Viral Vector Manufacturing Product Portfolio
6.8.5 Batavia Biosciences Recent Developments/Updates
6.9 Exothera
6.9.1 Exothera Company Information
6.9.2 Exothera Description and Business Overview
6.9.3 Exothera GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Exothera GMP Viral Vector Manufacturing Product Portfolio
6.9.5 Exothera Recent Developments/Updates
6.10 WuXi Biologics
6.10.1 WuXi Biologics Company Information
6.10.2 WuXi Biologics Description and Business Overview
6.10.3 WuXi Biologics GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.10.4 WuXi Biologics GMP Viral Vector Manufacturing Product Portfolio
6.10.5 WuXi Biologics Recent Developments/Updates
6.11 Vectorbuilder
6.11.1 Vectorbuilder Company Information
6.11.2 Vectorbuilder Description and Business Overview
6.11.3 Vectorbuilder GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vectorbuilder GMP Viral Vector Manufacturing Product Portfolio
6.11.5 Vectorbuilder Recent Developments/Updates
6.12 Abace-Biology
6.12.1 Abace-Biology Company Information
6.12.2 Abace-Biology Description and Business Overview
6.12.3 Abace-Biology GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Abace-Biology GMP Viral Vector Manufacturing Product Portfolio
6.12.5 Abace-Biology Recent Developments/Updates
6.13 Genscript
6.13.1 Genscript Company Information
6.13.2 Genscript Description and Business Overview
6.13.3 Genscript GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Genscript GMP Viral Vector Manufacturing Product Portfolio
6.13.5 Genscript Recent Developments/Updates
6.14 Cytiva
6.14.1 Cytiva Company Information
6.14.2 Cytiva Description and Business Overview
6.14.3 Cytiva GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cytiva GMP Viral Vector Manufacturing Product Portfolio
6.14.5 Cytiva Recent Developments/Updates
6.15 Obiosh
6.15.1 Obiosh Company Information
6.15.2 Obiosh Description and Business Overview
6.15.3 Obiosh GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Obiosh GMP Viral Vector Manufacturing Product Portfolio
6.15.5 Obiosh Recent Developments/Updates
6.16 Pregene
6.16.1 Pregene Company Information
6.16.2 Pregene Description and Business Overview
6.16.3 Pregene GMP Viral Vector Manufacturing Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Pregene GMP Viral Vector Manufacturing Product Portfolio
6.16.5 Pregene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GMP Viral Vector Manufacturing Industry Chain Analysis
7.2 GMP Viral Vector Manufacturing Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GMP Viral Vector Manufacturing Production Mode & Process Analysis
7.4 GMP Viral Vector Manufacturing Sales and Marketing
7.4.1 GMP Viral Vector Manufacturing Sales Channels
7.4.2 GMP Viral Vector Manufacturing Distributors
7.5 GMP Viral Vector Manufacturing Customer Analysis
8 GMP Viral Vector Manufacturing Market Dynamics
8.1 GMP Viral Vector Manufacturing Industry Trends
8.2 GMP Viral Vector Manufacturing Market Drivers
8.3 GMP Viral Vector Manufacturing Market Challenges
8.4 GMP Viral Vector Manufacturing Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global GMP Viral Vector Manufacturing Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global GMP Viral Vector Manufacturing Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global GMP Viral Vector Manufacturing Market Competitive Situation by Manufacturers in 2024
Table 4. Global GMP Viral Vector Manufacturing Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global GMP Viral Vector Manufacturing Sales Market Share by Manufacturers (2020-2025)
Table 6. Global GMP Viral Vector Manufacturing Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global GMP Viral Vector Manufacturing Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market GMP Viral Vector Manufacturing Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of GMP Viral Vector Manufacturing, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of GMP Viral Vector Manufacturing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GMP Viral Vector Manufacturing, Product Type & Application
Table 12. Global Key Manufacturers of GMP Viral Vector Manufacturing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GMP Viral Vector Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Viral Vector Manufacturing as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GMP Viral Vector Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global GMP Viral Vector Manufacturing Sales by Region (2020-2025) & (K Units)
Table 18. Global GMP Viral Vector Manufacturing Sales Market Share by Region (2020-2025)
Table 19. Global GMP Viral Vector Manufacturing Sales by Region (2026-2031) & (K Units)
Table 20. Global GMP Viral Vector Manufacturing Sales Market Share by Region (2026-2031)
Table 21. Global GMP Viral Vector Manufacturing Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global GMP Viral Vector Manufacturing Revenue Market Share by Region (2020-2025)
Table 23. Global GMP Viral Vector Manufacturing Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global GMP Viral Vector Manufacturing Revenue Market Share by Region (2026-2031)
Table 25. North America GMP Viral Vector Manufacturing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America GMP Viral Vector Manufacturing Sales by Country (2020-2025) & (K Units)
Table 27. North America GMP Viral Vector Manufacturing Sales by Country (2026-2031) & (K Units)
Table 28. North America GMP Viral Vector Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America GMP Viral Vector Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe GMP Viral Vector Manufacturing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe GMP Viral Vector Manufacturing Sales by Country (2020-2025) & (K Units)
Table 32. Europe GMP Viral Vector Manufacturing Sales by Country (2026-2031) & (K Units)
Table 33. Europe GMP Viral Vector Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe GMP Viral Vector Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific GMP Viral Vector Manufacturing Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific GMP Viral Vector Manufacturing Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific GMP Viral Vector Manufacturing Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific GMP Viral Vector Manufacturing Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific GMP Viral Vector Manufacturing Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America GMP Viral Vector Manufacturing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America GMP Viral Vector Manufacturing Sales by Country (2020-2025) & (K Units)
Table 42. Latin America GMP Viral Vector Manufacturing Sales by Country (2026-2031) & (K Units)
Table 43. Latin America GMP Viral Vector Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America GMP Viral Vector Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa GMP Viral Vector Manufacturing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa GMP Viral Vector Manufacturing Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa GMP Viral Vector Manufacturing Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa GMP Viral Vector Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa GMP Viral Vector Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global GMP Viral Vector Manufacturing Sales (K Units) by Type (2020-2025)
Table 51. Global GMP Viral Vector Manufacturing Sales (K Units) by Type (2026-2031)
Table 52. Global GMP Viral Vector Manufacturing Sales Market Share by Type (2020-2025)
Table 53. Global GMP Viral Vector Manufacturing Sales Market Share by Type (2026-2031)
Table 54. Global GMP Viral Vector Manufacturing Revenue (US$ Million) by Type (2020-2025)
Table 55. Global GMP Viral Vector Manufacturing Revenue (US$ Million) by Type (2026-2031)
Table 56. Global GMP Viral Vector Manufacturing Revenue Market Share by Type (2020-2025)
Table 57. Global GMP Viral Vector Manufacturing Revenue Market Share by Type (2026-2031)
Table 58. Global GMP Viral Vector Manufacturing Price (US$/Unit) by Type (2020-2025)
Table 59. Global GMP Viral Vector Manufacturing Price (US$/Unit) by Type (2026-2031)
Table 60. Global GMP Viral Vector Manufacturing Sales (K Units) by Application (2020-2025)
Table 61. Global GMP Viral Vector Manufacturing Sales (K Units) by Application (2026-2031)
Table 62. Global GMP Viral Vector Manufacturing Sales Market Share by Application (2020-2025)
Table 63. Global GMP Viral Vector Manufacturing Sales Market Share by Application (2026-2031)
Table 64. Global GMP Viral Vector Manufacturing Revenue (US$ Million) by Application (2020-2025)
Table 65. Global GMP Viral Vector Manufacturing Revenue (US$ Million) by Application (2026-2031)
Table 66. Global GMP Viral Vector Manufacturing Revenue Market Share by Application (2020-2025)
Table 67. Global GMP Viral Vector Manufacturing Revenue Market Share by Application (2026-2031)
Table 68. Global GMP Viral Vector Manufacturing Price (US$/Unit) by Application (2020-2025)
Table 69. Global GMP Viral Vector Manufacturing Price (US$/Unit) by Application (2026-2031)
Table 70. Advanced BioScience Laboratories Company Information
Table 71. Advanced BioScience Laboratories Description and Business Overview
Table 72. Advanced BioScience Laboratories GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Advanced BioScience Laboratories GMP Viral Vector Manufacturing Product
Table 74. Advanced BioScience Laboratories Recent Developments/Updates
Table 75. Biovian Company Information
Table 76. Biovian Description and Business Overview
Table 77. Biovian GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Biovian GMP Viral Vector Manufacturing Product
Table 79. Biovian Recent Developments/Updates
Table 80. Lonza Company Information
Table 81. Lonza Description and Business Overview
Table 82. Lonza GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Lonza GMP Viral Vector Manufacturing Product
Table 84. Lonza Recent Developments/Updates
Table 85. Takara Bio Company Information
Table 86. Takara Bio Description and Business Overview
Table 87. Takara Bio GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Takara Bio GMP Viral Vector Manufacturing Product
Table 89. Takara Bio Recent Developments/Updates
Table 90. Genezen Company Information
Table 91. Genezen Description and Business Overview
Table 92. Genezen GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Genezen GMP Viral Vector Manufacturing Product
Table 94. Genezen Recent Developments/Updates
Table 95. Halix Company Information
Table 96. Halix Description and Business Overview
Table 97. Halix GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Halix GMP Viral Vector Manufacturing Product
Table 99. Halix Recent Developments/Updates
Table 100. Merck Company Information
Table 101. Merck Description and Business Overview
Table 102. Merck GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Merck GMP Viral Vector Manufacturing Product
Table 104. Merck Recent Developments/Updates
Table 105. Batavia Biosciences Company Information
Table 106. Batavia Biosciences Description and Business Overview
Table 107. Batavia Biosciences GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Batavia Biosciences GMP Viral Vector Manufacturing Product
Table 109. Batavia Biosciences Recent Developments/Updates
Table 110. Exothera Company Information
Table 111. Exothera Description and Business Overview
Table 112. Exothera GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Exothera GMP Viral Vector Manufacturing Product
Table 114. Exothera Recent Developments/Updates
Table 115. WuXi Biologics Company Information
Table 116. WuXi Biologics Description and Business Overview
Table 117. WuXi Biologics GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. WuXi Biologics GMP Viral Vector Manufacturing Product
Table 119. WuXi Biologics Recent Developments/Updates
Table 120. Vectorbuilder Company Information
Table 121. Vectorbuilder Description and Business Overview
Table 122. Vectorbuilder GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Vectorbuilder GMP Viral Vector Manufacturing Product
Table 124. Vectorbuilder Recent Developments/Updates
Table 125. Abace-Biology Company Information
Table 126. Abace-Biology Description and Business Overview
Table 127. Abace-Biology GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Abace-Biology GMP Viral Vector Manufacturing Product
Table 129. Abace-Biology Recent Developments/Updates
Table 130. Genscript Company Information
Table 131. Genscript Description and Business Overview
Table 132. Genscript GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Genscript GMP Viral Vector Manufacturing Product
Table 134. Genscript Recent Developments/Updates
Table 135. Cytiva Company Information
Table 136. Cytiva Description and Business Overview
Table 137. Cytiva GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Cytiva GMP Viral Vector Manufacturing Product
Table 139. Cytiva Recent Developments/Updates
Table 140. Obiosh Company Information
Table 141. Obiosh Description and Business Overview
Table 142. Obiosh GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Obiosh GMP Viral Vector Manufacturing Product
Table 144. Obiosh Recent Developments/Updates
Table 145. Pregene Company Information
Table 146. Pregene Description and Business Overview
Table 147. Pregene GMP Viral Vector Manufacturing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Pregene GMP Viral Vector Manufacturing Product
Table 149. Pregene Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. GMP Viral Vector Manufacturing Distributors List
Table 153. GMP Viral Vector Manufacturing Customers List
Table 154. GMP Viral Vector Manufacturing Market Trends
Table 155. GMP Viral Vector Manufacturing Market Drivers
Table 156. GMP Viral Vector Manufacturing Market Challenges
Table 157. GMP Viral Vector Manufacturing Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report


List of Figures
Figure 1. Product Picture of GMP Viral Vector Manufacturing
Figure 2. Global GMP Viral Vector Manufacturing Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GMP Viral Vector Manufacturing Market Share by Type: 2024 & 2031
Figure 4. Adenovirus Vector Manufacturing Product Picture
Figure 5. AAV Vector Manufacturing Product Picture
Figure 6. Retroviral Vector Manufacturing Product Picture
Figure 7. Lentiviral Vector Manufacturing Product Picture
Figure 8. Others Product Picture
Figure 9. Global GMP Viral Vector Manufacturing Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global GMP Viral Vector Manufacturing Market Share by Application: 2024 & 2031
Figure 11. Clinical Research
Figure 12. Commercial Production
Figure 13. Others
Figure 14. Global GMP Viral Vector Manufacturing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global GMP Viral Vector Manufacturing Market Size (2020-2031) & (US$ Million)
Figure 16. Global GMP Viral Vector Manufacturing Sales (2020-2031) & (K Units)
Figure 17. Global GMP Viral Vector Manufacturing Average Price (US$/Unit) & (2020-2031)
Figure 18. GMP Viral Vector Manufacturing Report Years Considered
Figure 19. GMP Viral Vector Manufacturing Sales Share by Manufacturers in 2024
Figure 20. Global GMP Viral Vector Manufacturing Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest GMP Viral Vector Manufacturing Players: Market Share by Revenue in GMP Viral Vector Manufacturing in 2024
Figure 22. GMP Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global GMP Viral Vector Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America GMP Viral Vector Manufacturing Sales Market Share by Country (2020-2031)
Figure 25. North America GMP Viral Vector Manufacturing Revenue Market Share by Country (2020-2031)
Figure 26. United States GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe GMP Viral Vector Manufacturing Sales Market Share by Country (2020-2031)
Figure 29. Europe GMP Viral Vector Manufacturing Revenue Market Share by Country (2020-2031)
Figure 30. Germany GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific GMP Viral Vector Manufacturing Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific GMP Viral Vector Manufacturing Revenue Market Share by Region (2020-2031)
Figure 37. China GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America GMP Viral Vector Manufacturing Sales Market Share by Country (2020-2031)
Figure 45. Latin America GMP Viral Vector Manufacturing Revenue Market Share by Country (2020-2031)
Figure 46. Mexico GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa GMP Viral Vector Manufacturing Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa GMP Viral Vector Manufacturing Revenue Market Share by Country (2020-2031)
Figure 51. Turkey GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE GMP Viral Vector Manufacturing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of GMP Viral Vector Manufacturing by Type (2020-2031)
Figure 55. Global Revenue Market Share of GMP Viral Vector Manufacturing by Type (2020-2031)
Figure 56. Global GMP Viral Vector Manufacturing Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of GMP Viral Vector Manufacturing by Application (2020-2031)
Figure 58. Global Revenue Market Share of GMP Viral Vector Manufacturing by Application (2020-2031)
Figure 59. Global GMP Viral Vector Manufacturing Price (US$/Unit) by Application (2020-2031)
Figure 60. GMP Viral Vector Manufacturing Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies